ClinicalTrials.Veeva

Menu

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP (MOST)

University of Connecticut logo

University of Connecticut

Status and phase

Enrolling
Phase 4

Conditions

Opioid Use Disorder
Hiv

Treatments

Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Behavioral: community-friendly health recovery program

Study type

Interventional

Funder types

Other

Identifiers

NCT05669534
H22-0121

Details and patient eligibility

About

The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enhancing the ability of PWID on MOUD to process and utilize HIV prevention content, leading to improvements in HIV prevention information, motivation, behavioral skills, and behaviors (IMB).

Full description

Participants will be randomized to one of 16 conditions. In addition to receiving the Core Components of the CHRP behavioral intervention, participants will receive one of the sixteen combinations of four compensatory components that show promise in terms of enhancing the ability to process and utilize HIV prevention content (see conceptual figure above), and that are not currently part of CHRP. The Attention Component includes: (a) Increasing frequency of sessions (more than once per week); (b) Distributed practice (spreading out information across sessions); (c) More structured sessions (well-organized objectives shared with patients); (d) Introducing new information during closure (foreshadow content of next session). The Executive Function Component includes the following strategies: (a) Associating behavior with situational cues (anticipate risky situations); (b) Linking actions to a triggering cue (storytelling techniques using imagery); (c) Planning (identify and organize steps required to meet goal) and (d) Valuing future events (recognize the benefits of drug treatment). Similarly, the Memory Component involves: (a) Memory aids (reminders and cues to be used between sessions); (b) Summarizing/reiterating information (frequent review throughout sessions); (c) Prospective memory (emphasize routine, develop cues, elaborate on positive behaviors); and (d) Environmental engineering (prepare for adverse events). Lastly, the Information Processing Component includes: (a) Mixed methods of presentation (verbal, visual, and hands-on); (b) Simple language (clear, concrete examples aligned with health literacy level); (c) Present content slowly (allow extra time for responses); and (d Immediate feedback following assessment (oral/ written).Of particular note, the investigators are using this framework to examine all combinations of these components (rather than merely testing all four) to promote ecological validity and future implementation. Specifically, our approach will help determine the most resource-efficient intervention, as there are many barriers to adding components to standard of care in these clinical settings. For example, if components targeting only two domains can produce equivalent outcomes as components targeting four, the former would be identified as preferred

Enrollment

256 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • being 18 years or older
  • meeting DSM-V criteria for opioid dependence and being newly prescribed and adherent to Medication for Opioid Use Disorder (e.g., methadone, buprenorphine) at the APT Foundation, Inc.
  • showing mild cognitive impairment based on the Montreal Cognitive Assessment (MoCA) screening
  • having initiated Pre-Exposure Prophylaxis (PrEP) within the past week
  • confirming HIV-negative status through proof of PrEP prescription
  • reporting unsafe injection drug use practices or unprotected sex within the past 3 months
  • having a cell phone
  • being able to read and understand in English

Exclusion criteria

  • unable to provide consent
  • actively suicidal
  • actively homicidal
  • actively psychotic
  • display MoCA scores suggestive of dementia

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

256 participants in 16 patient groups

Condition 1
Active Comparator group
Description:
Standard CHRP Intervention Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 2
Experimental group
Description:
Standard CHRP Intervention Components and Information Processing Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 3
Experimental group
Description:
Standard CHRP Intervention Components and Memory Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 4
Experimental group
Description:
Standard CHRP Intervention Components, Information Processing Components, and Memory Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 5
Experimental group
Description:
Standard CHRP Intervention Components, Executive Functioning Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 6
Experimental group
Description:
Standard CHRP Intervention Components, Information Processing Components, and Executive Functioning Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 7
Experimental group
Description:
Standard CHRP Intervention Components, Memory Components, and Executive Functioning Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 8
Experimental group
Description:
Standard CHRP Intervention Components, Information Processing Components, Memory Components, and Executive Functioning Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 9
Experimental group
Description:
Standard CHRP Intervention Components and Attention Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 10
Experimental group
Description:
Standard CHRP Intervention Components, Information Processing Components, and Attention Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 11
Experimental group
Description:
Standard CHRP Intervention Components, Memory Components, and Attention Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 12
Experimental group
Description:
Standard CHRP Intervention Components, Information Processing Components, Memory Components, and Attention Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 13
Experimental group
Description:
Standard CHRP Intervention Components, Executive Functioning Components, and Attention Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 14
Experimental group
Description:
Standard CHRP Intervention Components, Executive Functioning Components, Attention Components, and Information Processing Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 15
Experimental group
Description:
Standard CHRP Intervention Components, Executive Functioning Components, Attention Components, and Information Processing Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis
Condition 16
Experimental group
Description:
Standard CHRP Intervention Components, Executive Functioning Components, Attention Components, Information Processing Components, and Memory Components
Treatment:
Behavioral: community-friendly health recovery program
Drug: Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis

Trial contacts and locations

1

Loading...

Central trial contact

Tanya Adler, MS; Brian Sibilio, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems